Aqr Capital Management LLC Pds Biotechnology Corp Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.55 - $4.02 $3,314 - $5,225
1,300 Added 6.23%
22,156 $64,000
Q1 2024

May 15, 2024
SELL
$3.85 - $6.59 $32,374 - $55,415
-8,409 Reduced 28.73%
20,856 $82,000
Q4 2023

Feb 14, 2024
BUY
$3.95 - $6.58 $27,010 - $44,994
6,838 Added 30.49%
29,265 $145,000
Q3 2023

Nov 14, 2023
BUY
$4.8 - $6.4 $107,649 - $143,532
22,427 New
22,427 $113,000

Others Institutions Holding PDSB

# of Institutions
64
Shares Held
4.32M
Call Options Held
253K
Put Options Held
70.4K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $47M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email